Cargando…

An Algorithm for Preclinical Diagnosis of Alzheimer's Disease

Almost all Alzheimer's disease (AD) therapeutic trials have failed in recent years. One of the main reasons for failure is due to designing the disease-modifying clinical trials at the advanced stage of the disease when irreversible brain damage has already occurred. Diagnosis of the preclinica...

Descripción completa

Detalles Bibliográficos
Autor principal:	Khan, Tapan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936981/ https://www.ncbi.nlm.nih.gov/pubmed/29760644 http://dx.doi.org/10.3389/fnins.2018.00275

Ejemplares similares

Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease
por: Kulason, Sue, et al.
Publicado: (2020)

The effects of automated artifact removal algorithms on electroencephalography-based Alzheimer's disease diagnosis
por: Cassani, Raymundo, et al.
Publicado: (2014)

Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2015)

Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease
por: Younes, Laurent, et al.
Publicado: (2019)

Baseline White Matter Is Associated With Physical Fitness Change in Preclinical Alzheimer’s Disease
por: Venkatraman, Vijay K., et al.
Publicado: (2020)

Changes of Regional Neural Activity Homogeneity in Preclinical Alzheimer’s Disease: Compensation and Dysfunction
por: Zhang, Zhen, et al.
Publicado: (2021)

Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
por: Fiandaca, Massimo S., et al.
Publicado: (2015)

Preclinical diagnosis of Alzheimer’s disease: Prevention or prediction?
por: Nitrini, Ricardo
Publicado: (2010)

The Biomarkers for Identifying Preclinical Alzheimer's Disease via Structural and Functional Magnetic Resonance Imaging
por: Zhou, Yanhong, et al.
Publicado: (2016)

A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019)

Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer’s Disease
por: Cope, Zackary A., et al.
Publicado: (2022)

Urinary Incontinence and Alzheimer’s Disease: Insights From Patients and Preclinical Models
por: Bartolone, Sarah N., et al.
Publicado: (2021)

Subjective Cognitive Decline as a Preclinical Marker for Alzheimer's Disease: The Challenge of Stability Over Time
por: Ávila-Villanueva, Marina, et al.
Publicado: (2017)

Distinct Disruptive Patterns of Default Mode Subnetwork Connectivity Across the Spectrum of Preclinical Alzheimer’s Disease
por: Xue, Chen, et al.
Publicado: (2019)

Transcranial Direct Current Stimulation Alleviates Neurovascular Unit Dysfunction in Mice With Preclinical Alzheimer’s Disease
por: Luo, Yinpei, et al.
Publicado: (2022)

Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD
por: Schindler, Suzanne Elizabeth, et al.
Publicado: (2015)

Effect of acupuncture on neuroinflammation in animal models of Alzheimer’s disease: A preclinical systematic review and meta-analysis
por: Wu, Zhi-Guo, et al.
Publicado: (2023)

Differential Abnormality in Functional Connectivity Density in Preclinical and Early-Stage Alzheimer's Disease
por: Song, Yu, et al.
Publicado: (2022)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Multiplex Networks for Early Diagnosis of Alzheimer's Disease
por: Amoroso, Nicola, et al.
Publicado: (2018)

Diagnosis of Alzheimer’s Disease Using Brain Network
por: Lama, Ramesh Kumar, et al.
Publicado: (2021)

Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease
por: Ning, Shen, et al.
Publicado: (2022)

Evaluation of Feature Selection for Alzheimer’s Disease Diagnosis
por: Gu, Feng, et al.
Publicado: (2022)

Kaixinsan, a Well-Known Chinese Herbal Prescription, for Alzheimer's Disease and Depression: A Preclinical Systematic Review
por: Fu, Huan, et al.
Publicado: (2020)

Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2021)

The preservation of right cingulum fibers in subjective cognitive decline of preclinical phase of Alzheimer’s disease
por: Sun, Yu, et al.
Publicado: (2023)

Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging
por: Díaz-Álvarez, Josefa, et al.
Publicado: (2022)

Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
por: Baig, Mohammad H., et al.
Publicado: (2018)

microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2015)

Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
por: Rani, Palaniswamy, et al.
Publicado: (2017)

Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
por: Gong, Xun, et al.
Publicado: (2022)

Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
por: Insel, Philip S., et al.
Publicado: (2017)

Altered Frequency-Dependent Brain Activation and White Matter Integrity Associated With Cognition in Characterizing Preclinical Alzheimer’s Disease Stages
por: Wang, Siyu, et al.
Publicado: (2021)

Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease
por: Jutten, Roos J., et al.
Publicado: (2022)

N-Truncated Aβ Starting at Position Four—Biochemical Features, Preclinical Models, and Potential as Drug Target in Alzheimer’s Disease
por: Bayer, Thomas A.
Publicado: (2021)

Comparison of nine tractography algorithms for detecting abnormal structural brain networks in Alzheimer’s disease
por: Zhan, Liang, et al.
Publicado: (2015)

Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer's Disease: A Systematic Review
por: Sarica, Alessia, et al.
Publicado: (2017)

Discriminant Subspace Low-Rank Representation Algorithm for Electroencephalography-Based Alzheimer’s Disease Recognition
por: Tang, Tusheng, et al.
Publicado: (2022)

Routine lumbar puncture for the early diagnosis of Alzheimer's disease. Is it safe?
por: Menéndez-González, Manuel
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ojonpilv68m1ibel2oma1b31h9